CD4+ T-Lymphocyte-Induced Epstein-Barr Virus Reactivation in a Patient with Severe Hypersensitivity to Mosquito Bites and Epstein-Barr Virus-Infected NK Cell Lymphocytosis

Archives of Dermatology

Volumn 139, Issue 12, 2003, Pages 1601-1607

  Asada, Hideo ^a,b   Miyagawa, Sachiko ^a   Sumikawa, Yasuyuki ^b   Yamaguchi, Yuji ^b   Itami, Satoshi ^b   Suguri, Setsuo ^d   Harada, Masakazu ^d   Tokura, Yoshiki ^c   Ishihara, Shigehiko ^e   Ohshima, Shiro ^b   Yoshikawa, Kunihiko ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e Yawata Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; TISSUE EXTRACT; VIRUS DNA; VIRUS PROTEIN;

ADULT; ARTICLE; BZLF1 GENE; CASE REPORT; COCULTURE; EPSTEIN BARR VIRUS; FEMALE; GENE; GENE EXPRESSION; GENE NUMBER; HUMAN; HUMAN TISSUE; HYPERSENSITIVITY REACTION; INFECTIOUS MONONUCLEOSIS; INSECT BITE; LATENT VIRUS INFECTION; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; MOSQUITO; MOSQUITO BITE HYPERSENSITIVITY; NATURAL KILLER CELL; NATURAL KILLER CELL LYMPHOCYTOSIS; PATCH TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SKIN DEFECT; SYMPTOMATOLOGY; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS REACTIVATION;

ADOLESCENT; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COMPUTER GRAPHICS; CULICIDAE; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; HYPERSENSITIVITY; IN SITU HYBRIDIZATION; INSECT BITES AND STINGS; KILLER CELLS, NATURAL; LYMPHOCYTOSIS; SKIN TESTS; VIRUS ACTIVATION;

EID: 10744233516     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.12.1601     Document Type: Article

References (22)

1. Hidano A, Kawakami M, Yago A. Hypersensitivity to mosquito bite and malignant histocytosis. Jpn J Exp Med. 1982;52:303-306.
2. Tokura Y, Tamura Y, Takigawa M, et al. Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol. 1990;126:362-368.
3. Ishihara S, Ohshima K, Tokura Y, et al. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res. 1997;88:82-87.
4. Mizuki M, Ueda S, Tagawa S, et al. Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection. Am J Hematol. 1998;59:309-315.
5. Ohshima S, Ishii M, Asada H, et al. A possible mechanism of NK cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) in a patient with chronic active Epstein-Barr virus infection (CAEBV) and severe hypersensitivity to mosquito bites (SHMB). Intern Med. 2002;41:651-656.
6. Asada H, Okada N, Hashimoto K, et al. Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia. Leukemia. 1994;8:1415-1423.
7. Prang NS, Hornef MW, Jager M, Wagner HJ, Wolf H, Schwarzmann FM. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood. 1997;89:1665-1677.
8. Futscher BW, Blake LL, Gerlach JH, Grogan TM, Dalton WS. Quantitative polymerase chain reaction analysis of mdrI mRNA in multiple myeloma cell lines and clinical specimens. Anal Biochem. 1993;213:414-421.
9. Thomas TE, Sutherland H J, Lansdorp PM. Specific binding and release of cells from beads using cleavable tetrameric antibody complexes. J Immunol Methods. 1989;120:221-231.
10. Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 1999; 59:1188-1191.
11. Ishihara S, Yabuta R, Tokura Y, Ohshima K, Tagawa S. Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease. Int J Hematol. 2000;72:223-228.
12. Tsai WC, Luo SF, Liaw SJ, Kuo TT. Mosquito bite allergies terminating as hemophagocytic histiocytosis: report of a case. Taiwan Yi Xue Hui Za Zhi. 1989; 88:639-642.
13. Fan PC, Chang HN. Hypersensitivity to mosquito bite: a case report. Gaoxiong Yi Xue Ke Xue Za Zhi. 1995;11:420-424.
14. Ruiz-Maldonado R, Pamila FM, Orozco-Covarrubias ML, Ridaura C, Tamayo Sanchez L, Duran McKinster C. Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol. 1995;32:37-44.
15. Tokura Y, Ishihara S, Ohshima K, et al. Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption. Br J Dermatol. 1998;138:905-906.
16. Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneko F. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol. 1997;133:1081-1086.
17. Lamy T, Loughran TPJ. Current concepts: large granular lymphocyte leukemia. Blood Rev. 1999;13:230-240.
18. Fu Z, Cannon MJ. Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression. J Virol. 2000;74:6675-6679.
19. Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen. J Exp Med. 1996;184:971-980.
20. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 2001;15:579-589.
21. Asada H, Okada N, Tei H, et al. Epstein-Barr virus-associated large granular lymphocyte leukemia with cutaneous infiltration. J Am Acad Dermatol. 1994;31:251-255.
22. Cho KH, Kim CW, Lee DY, Sohn SJ, Kim DW, Chung JH. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face. Br J Dermatol. 1996;134:791-796.